Clinical Trial

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).
Protocol Amendment History 5 changes
critical Phase changed: not applicable -> Phase 1 2026-07-01
notable Enrollment reduced: 160 -> 40 participants 2026-07-01
minor Trial arms changed: 2 -> 1 2026-07-01
notable Primary completion pushed: 2026-08-01 -> 2027-08-31 2026-07-01
minor Completion pushed: 2026-08-01 -> 2027-08-31 2026-07-01
Trial Details
NCT Number NCT07158853
Lead Sponsor University of Minnesota
Conditions Opioid Use Disorder
Enrollment 40 participants
Start Date 2026-02-04
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-06